A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleA Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJong-Seok Lee, Jinseok Kim